Ziopharm Oncology

Develops immunotherapies for the treatment of cancer and autoimmune diseases

placeBoston, Massachusetts, United States calendar_todayFounded 2003 groups36 employees language ziopharm.com

Registered entities

Investor mix

15 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital533%
Private equity320%
Accelerator & incubator17%
Bank & private debt213%
Other / undisclosed427%
Coming soon